Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer says.

Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer ...

While the risk of COPD was highest among traditional cigarette smokers and dual users, e-cigarette users also had a significantly increased risk of COPD over people who’d never used e-cigarettes or ...

Let’s not forget the big elephant in the season-change room: allergies. They can cause airway inflammation and worsen COPD symptoms. The best defense against allergens is to avoid them as much as ...

In the late 1960s and early ’70s, nearly all of the steel mills in the upper Ohio Valley were fueled by metallurgical coal. That kind of coal is used to make coke, a pure form of carbon that fuels the ...

Fluticasone-salmeterol (brand name, Advair Diskus; GSK) is an inhalation maintenance treatment for breathing difficulties caused by COPD, such as wheezing, shortness of breath, coughing, and chest ...

COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for ...

Abrysvo was already cleared in the U.S. for adults older than 60 and pregnant people at 32-36 weeks of gestation to protect infants from birth to age 6 months. With the new authorization, Abrysvo ...

The Verona Pharma therapy, with a list price of $2,950 for a monthly supply, was cleared by the U.S. Food and Drug Administration in June as an inhaled maintenance therapy for adults with COPD. “We ...